Keyphrases
Acute Exacerbation of COPD (AECOPD)
90%
Eosinophils
60%
Noninvasive Ventilation
60%
COPD Patients
39%
Chronic Obstructive Pulmonary Disease
38%
Quality of Life
38%
Systemic Corticosteroids
35%
Activities of Daily Living
30%
Open-label Trial
30%
Task Performance
30%
Treatment Discontinuation
30%
Position Paper
30%
Non-inferiority Trial
30%
Acute Alcohol Consumption
30%
Hospitalized Patients
30%
Nonmalignant
30%
Corticosteroid-sparing
30%
Number of Admissions
30%
Increased Mortality
30%
Daily Tasks
30%
Chronic Progressive
30%
Treatment Limitation
30%
Smokers
30%
Palliative Care
30%
Informal Caregivers
22%
Palliation
22%
Prednisolone
21%
Denmark
16%
Access to Palliative Care
15%
Stable Phase
15%
Time-sensitive Communication
15%
Patient Caregivers
15%
Life-sustaining Treatment
15%
Health Authorities
15%
Patient Demand
15%
Symptom Burden
15%
Disease Progression
15%
Interstitial Lung Disease
15%
Disease Stage
15%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
100%
Eosinophil
60%
Symptomatic Treatment
45%
Corticosteroid Therapy
37%
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
36%
Silo-Filler's Disease
35%
Lung
33%
Quality of Life
32%
Corticosteroid
31%
Disease Exacerbation
30%
Open-Label Trial
30%
Noninferiority Trial
30%
Pulmonary Disorder
30%
Respiratory Failure
30%
Noninvasive Ventilation
30%
Smoking
30%
Diseases
24%
Prednisolone
21%
Biological Marker
17%
Life Sustaining Treatment
15%
